Table of Contents

DENMARK 1

HEALTHCARE SYSTEM 1
Facts & Figures 1
Market Indicators 2
Provision & Funding 4
Healthcare System 4
Healthcare Funding 4
Provision of Care 5
Private Insurance 5

PRICING 6
Prescription Drugs 6
Generic Drugs 6
Hospital Drugs 7
Pricing Regulations 7
Actual Prices 8
Tenders 8
OTC Drugs 8

REIMBURSEMENT 9
Admission to Reimbursement 9
Application Process 9
Decision Making 9
General Reimbursement 10
Individual Reimbursement 11
Reimbursement Categories 12
Reimbursement Prices 12
Multisource Products 12
Single Source Products 12
Hospital Reimbursement 12
Hospital Formularies 12
Medicine Council 13
Council for the Use of High-Cost Hospital Medicines (RADS) 17
The Co-ordination Council for the Use of Hospital Medicines (KRIS) 18
Hospital Funding 20
Changes in Reimbursement Status 20
Reimbursement List Updates 20
Reimbursement Reassessments. 20
New Presentations and Indications 24
Changes in Reimbursement Prices 24
Price Changes 24
Primary Care Price Cap Agreement 24
Fortnightly Price List 25

PHARMACOECONOMICS 26
Pharmacoeconomic Requirements 26
Retail Drugs 26
Hospital Drugs 26

PRICE BUILD UP 27
Wholesalers 27
Margins 27
Background 27
Retail Pharmacies 27
Margins 27
Discounts 28
Background 28
E-pharmacy 30
Dose Dispensing 30
Dispensing Doctors 30
Sales Tax 30

COST CONTAINMENT 31
Industry Paybacks 31
Promotional Costs 31
Patient Co-payments 31
Pharmaceuticals 31
Healthcare 32
Supplementary Insurance 32
Prescribing Controls 33
National Measures 33
Regional Measures 35
Generics 35
Substitution 35
Rx-to-OTC Switches 36
Status Changes 36
Two-year Period of Pharmacy-only Sales 36
Liberalised OTC Sales 37
Direct Patient Access to OTCs 37
Parallel Trade 37

FUTURE DEVELOPMENTS 38
Outlook 38

NAMES & ADDRESSES 39